secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K/A
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001104659-23-099351
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron board adopts annual say-on-pay vote frequency after shareholder approval
--------------------------------------------------------------------------------

- Shareholders voted for every-one-year frequency at June 9, 2023 annual meeting.
- Board on Sept 8, 2023 determined future advisory votes on exec compensation will be held annually.
- Amendment filed solely to disclose the board's decision; no other changes to original report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465923099351/0001104659-23-099351-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465923099351/tm2325712d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-099351

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer